PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 1, 2005Diabetes211 citationsOpen Access

Factors Associated With Frequent Remission of Microalbuminuria in Patients With Type 2 Diabetes

SAShin‐ichi ArakiMHMasakazu HanedaTSToshiro Sugimoto

Structured PICO

What factors are associated with the remission or regression of microalbuminuria in Japanese patients with type 2 diabetes?

P
Population
216 Japanese patients with type 2 diabetes and microalbuminuria
O
Outcome
Remission of microalbuminuria (shift to normoalbuminuria) and regression (50% reduction in urinary albumin excretion rate)surrogate

Remission and regression of microalbuminuria are frequent in Japanese patients with type 2 diabetes and are associated with early detection, RAS blockade, and strict glycemic and blood pressure control.

Abstract

To estimate the frequency of remission/regression of microalbuminuria and to identify factors affecting such outcomes in Japanese patients with type 2 diabetes, we observed 216 patients with type 2 diabetes and microalbuminuria enrolled during an initial 2-year evaluation period for the next 6 years. Remission was defined as shift to normoalbuminuria and regression as a 50% reduction in urinary albumin excretion rate (AER) from one 2-year period to the next. Reduction of urinary AER was frequent, with a 6-year cumulative incidence of 51% (95% CI 42-60) for remission and 54% (45-63) for regression, whereas the frequency of progression to overt proteinuria was 28% (19-37). Microalbuminuria of short duration, the use of renin-angiotensin system-blocking drugs, and lower tertiles for HbA(1c) (<6.95%) and systolic blood pressure (<129 mmHg) were independently associated with remission or regression in the pooled logistic regression analysis. The results indicate that reduction in urinary AER occurs frequently in Japanese patients with type 2 diabetes. Early detection of microalbuminuria and a multifactorial control may result in improved outcomes for diabetic nephropathy and cardiovascular events.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Araki et al. (2005) studied this question.

synapsesocial.com/papers/69dd38e83f27c4971e99b364https://doi.org/10.2337/diabetes.54.10.2983
Ask AI
Helpful
Bookmark
Share
View Full Paper